Clincosm LogoSign in Get a demo

Long-term Cardiovascular Risk in Cured Cushing's Patients

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT00881283
Collaborator
(none)
1
Enrollment
1
Location
18.7
Actual Duration (Months)
0.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients
    Actual Study Start Date :
    Sep 8, 2008
    Actual Primary Completion Date :
    Mar 30, 2010
    Actual Study Completion Date :
    Mar 30, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    cured Cushing's disease

    Outcome Measures

    Primary Outcome Measures

    1. adipokine measurements [baseline]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 55 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients who have been cured of Cushing's disease at least 5 years ago.
    Exclusion Criteria:
    • patients who have been cured of Cushing's disease more than 15 years ago.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Neuroendocrine Clinical Center Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: Anne Klibanski, MD, Massachusetts General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karen Klahr Miller, MD, Chief, Neuroendocrine Unit, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT00881283
    Other Study ID Numbers:
    • 2008-p-001379
    First Posted:
    Apr 15, 2009
    Last Update Posted:
    Sep 2, 2020
    Last Verified:
    Aug 1, 2020
    Keywords provided by Karen Klahr Miller, MD, Chief, Neuroendocrine Unit, Massachusetts General Hospital
    Cushing's disease
    Additional relevant MeSH terms:
    ACTH-Secreting Pituitary Adenoma
    Pituitary ACTH Hypersecretion

    Study Results

    No Results Posted as of Sep 2, 2020